search
Back to results

Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis

Primary Purpose

Juvenile Idiopathic Arthritis

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Assessing exercise behavior
Sponsored by
Saime Nilay Arman
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Juvenile Idiopathic Arthritis focused on measuring Juvenile Idiopathic Arthritis, exercise, behavior

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed as JIA according to ILAR classification
  • Aged between 6-18
  • Adequate cognitive function for understanding questions

Exclusion Criteria:

- a parent who does not have a smartphone

Sites / Locations

  • Istanbul University-Cerrahpasa

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Assessing exercise behavior

Arm Description

determining exercise behaviour in patients with JIA by using specific scales

Outcomes

Primary Outcome Measures

11-point Numeric Analogue Scale
Exercise Stages of Change Scale-Short Form
Exercise Self-Efficacy Scale
Decisional Balance Scale

Secondary Outcome Measures

Full Information

First Posted
November 3, 2018
Last Updated
July 27, 2020
Sponsor
Saime Nilay Arman
search

1. Study Identification

Unique Protocol Identification Number
NCT03731520
Brief Title
Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis
Official Title
Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
April 5, 2018 (Actual)
Primary Completion Date
December 30, 2018 (Actual)
Study Completion Date
January 15, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Saime Nilay Arman

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Juvenile idiopathic arthritis (JIA) is one of the most common rheumatic diseases in childhood, affecting at least 1 in 1000 children. Children with JIA experience joint inflammation and swelling, pain and tenderness, morning stiffness, limited mobility. Children with JIA complain pain and have lower functional ability and decreased quality of life compared with their peers. Many studies have reported that patients with JIA have low physical activity levels and also exercise therapy is considered an important component of the treatment of JIA. Nowadays, studies for evaluating exercise behaviours in order to cope with physical inactivity for many chronic diseases are becoming increasingly important.The objective of this study is to determine exercise behaviour in patients with JIA.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Juvenile Idiopathic Arthritis
Keywords
Juvenile Idiopathic Arthritis, exercise, behavior

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Assessing exercise behavior
Arm Type
Experimental
Arm Description
determining exercise behaviour in patients with JIA by using specific scales
Intervention Type
Diagnostic Test
Intervention Name(s)
Assessing exercise behavior
Intervention Description
11-point Numeric Analogue Scale (NRS) for satisfaction of exercising, Exercise Stages of Change Scale-Short Form (ESCS), Exercise Self-Efficacy Scale (ESES), and Decisional Balance Scale (DBS) for exercise behaviour will be inquired for the patients with JIA.
Primary Outcome Measure Information:
Title
11-point Numeric Analogue Scale
Time Frame
baseline
Title
Exercise Stages of Change Scale-Short Form
Time Frame
baseline
Title
Exercise Self-Efficacy Scale
Time Frame
baseline
Title
Decisional Balance Scale
Time Frame
baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed as JIA according to ILAR classification Aged between 6-18 Adequate cognitive function for understanding questions Exclusion Criteria: - a parent who does not have a smartphone
Facility Information:
Facility Name
Istanbul University-Cerrahpasa
City
İstanbul
ZIP/Postal Code
34740
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Determination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis

We'll reach out to this number within 24 hrs